Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Other Non-Current Liabilities (2016 - 2021)

Historic Other Non-Current Liabilities for Neurocrine Biosciences (NBIX) over the last 12 years, with Q3 2021 value amounting to $8.3 million.

  • Neurocrine Biosciences' Other Non-Current Liabilities rose 9302.33% to $8.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $8.3 million, marking a year-over-year increase of 9302.33%. This contributed to the annual value of $9.7 million for FY2020, which is 4327.49% down from last year.
  • As of Q3 2021, Neurocrine Biosciences' Other Non-Current Liabilities stood at $8.3 million, which was up 9302.33% from $29.0 million recorded in Q2 2021.
  • Over the past 5 years, Neurocrine Biosciences' Other Non-Current Liabilities peaked at $35.7 million during Q4 2018, and registered a low of $113000.0 during Q1 2017.
  • Its 5-year average for Other Non-Current Liabilities is $14.7 million, with a median of $15.9 million in 2019.
  • Per our database at Business Quant, Neurocrine Biosciences' Other Non-Current Liabilities crashed by 6323.84% in 2020 and then surged by 9302.33% in 2021.
  • Neurocrine Biosciences' Other Non-Current Liabilities (Quarter) stood at $113000.0 in 2017, then surged by 31454.87% to $35.7 million in 2018, then crashed by 52.04% to $17.1 million in 2019, then crashed by 43.27% to $9.7 million in 2020, then decreased by 14.43% to $8.3 million in 2021.
  • Its Other Non-Current Liabilities stands at $8.3 million for Q3 2021, versus $29.0 million for Q2 2021 and $21.3 million for Q1 2021.